SAN ANTONIO, Tx - Cancer patients need a lot of drugs—immunotherapies, chemotherapies, and anti-infectives. But new research at ObesityWeek® on Nov. 3, 2024, shows clinicians may not have all the ...

BeiGene's TEVIMBRA expands for cancer treatment, and BRUKINSA sales soar 107%. See why BGNE stock presents upside potential ...

There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight ...

Purpose: The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for ...

Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term ...

The Daily Results line is designed for retailers who want to offer national brand equivalent products but have not developed ...

The gene therapy improved annualized bleed rates, though a handful of study participants resumed factor IX prophylaxis.

Fidelis Animal Health, Inc. has received notification from the Food and Drug Administration (FDA) that Ethiqa XR (buprenorphine extended-release injectable suspension) 1.3 mg/mL is now indicated for ...

Barber, who is 49 and lives in Kentucky, threw up constantly, so much that she started sleeping on the couch with a garbage ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

Organon (NYSE:OGN) projected a roughly 75 basis-point headwind to the company’s 2025 EBITDA margin on Tuesday after the FDA delayed a potential label expansion for its skin disorder therapy VTAMA ...

The grocery store is inundated with marketing terms intended to help consumers identify what they're purchasing, but what ...